Takeda Pharmaceutical Co Ltd (TAK)
13.04
-0.04
(-0.27%)
USD |
NYSE |
Apr 26, 16:00
13.04
0.00 (0.00%)
After-Hours: 17:43
Takeda Pharmaceutical Gross Profit (Quarterly): 4.956B for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.956B |
September 30, 2023 | 4.843B |
June 30, 2023 | 5.375B |
March 31, 2023 | 4.894B |
December 31, 2022 | 5.395B |
September 30, 2022 | 5.044B |
June 30, 2022 | 5.245B |
March 31, 2022 | 4.863B |
December 31, 2021 | 5.453B |
September 30, 2021 | 5.170B |
June 30, 2021 | 6.471B |
March 31, 2021 | 4.880B |
December 31, 2020 | 5.588B |
September 30, 2020 | 5.081B |
June 30, 2020 | 5.239B |
March 31, 2020 | 4.807B |
December 31, 2019 | 5.332B |
September 30, 2019 | 5.042B |
June 30, 2019 | 5.071B |
March 31, 2019 | 3.953B |
December 31, 2018 | 3.201B |
September 30, 2018 | 2.871B |
June 30, 2018 | 3.019B |
March 31, 2018 | 2.676B |
December 31, 2017 | 3.062B |
Date | Value |
---|---|
September 30, 2017 | 2.807B |
June 30, 2017 | 2.946B |
March 31, 2017 | 2.478B |
December 31, 2016 | 2.910B |
September 30, 2016 | 2.690B |
June 30, 2016 | 2.765B |
March 31, 2016 | 2.442B |
December 31, 2015 | 2.833B |
September 30, 2015 | 2.631B |
June 30, 2015 | 2.681B |
March 31, 2015 | 2.545B |
December 31, 2014 | 3.054B |
September 30, 2014 | 2.995B |
June 30, 2014 | 2.869B |
March 31, 2014 | 2.762B |
December 31, 2013 | 3.259B |
September 30, 2013 | 3.010B |
June 30, 2013 | 2.961B |
March 31, 2013 | 2.613B |
December 31, 2012 | 3.469B |
September 30, 2012 | 3.509B |
June 30, 2012 | 3.680B |
March 31, 2012 | 3.196B |
December 31, 2011 | 3.614B |
September 30, 2011 | 3.404B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
4.807B
Minimum
Mar 2020
6.471B
Maximum
Jun 2021
5.197B
Average
5.081B
Median
Sep 2020
Gross Profit (Quarterly) Benchmarks
Hoya Corp | 1.184B |
Otsuka Holdings Co Ltd | 2.530B |
Nxera Pharma Co Ltd | 37.53M |
PeptiDream Inc | 20.24M |
Stemcell Holdings Inc | 2.657M |